SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek's list of The World's Best Digital Health Companies 2024. This prestigious award was presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The list of awardees was unveiled on April 24th, 2024, and is available on the Newsweek website. Augmedix's inclusion highlights its commitment to empowe ...

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry's first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (NYSE:HCA), one of the nation's leading healthcare providers. ...

SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care. The alliance aims to harness the power of ambient documentation to transform the clinician-patient interaction ...

SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an Insight company, a leading cloud business and technology consultancy. The collaboration is focused on leveraging the companies' combined technology expertise and expanding their reach to provide greater product and service value to health systems seeking high-quality ambient documentation and structured data prod ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number: 001-40890 AUGMEDIX, INC. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------- ...

ljubaphoto/E+ via Getty Images Augmedix (NASDAQ:AUGX) is a company developing AI-driven medical documentation platform for hospital and physicians Share performance has been underwhelming since going public in 2021 at the price of $5. All-time return stands at -15% today, with the stock most recently trading at $4.3. The weak all-time return is partially driven by the lackluster performance YTD. Having reached $5.8 at the start of the year in January, share price has continued to trend down since. AUGX ...

Investor Presentation Nasdaq: AUGX March 2024 ...

Augmedix, Inc. (NASDAQ:AUGX) Q4 2023 Earnings Conference Call March 18, 2024 4:30 PM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Elizabeth Anderson - Evercore Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group Yuan Zhi - B. Riley Securities William Sutherland - The Benchmark Company Operator Greetings and welcome to Augmedix's Fourth Quart ...

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. "The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially," stated Augmedix CEO Manny Krakaris. "We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in service and n ...

SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go, its ambient AI medical documentation product. Now supporting over 50 medical specialties, the Augmedix Go mobile app optimizes ambient AI technology to produce comprehensive draft medical notes in real time by processing the natural conversations between clinicians and patients. New data from sur ...